Search

Your search keyword '"Tijero, Beatriz"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Tijero, Beatriz" Remove constraint Author: "Tijero, Beatriz"
192 results on '"Tijero, Beatriz"'

Search Results

13. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

16. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

17. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

18. H35 Cognitive and neuropsychiatric differences between asymptomatic and symptomatic carriers of Huntington´s disease

19. Pearls & Oy-sters: Challenges and Controversies in Wilson Disease

21. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson’s Disease

22. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies

23. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

24. Differences in visual-cognitive performance between asymptomatic and symptomatic carriers of Huntington’s disease (P3-11.002)

30. Autores

31. F15 Visual-cognitive impairment in asymptomatic and symptomatic carriers of huntington’s disease (HD)

34. Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project

35. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease

36. Retinal thickness predicts the risk of cognitive decline in Parkinson's disease

37. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project

39. Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease

44. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases

45. The value of non-motor features and genetic variants of Parkinson’s disease for clustering Lewy body diseases

47. Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease.

48. Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders

49. Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy

50. Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Catalog

Books, media, physical & digital resources